Thursday, November 20, 2008 - 7:09PM EST

Drug Therapy

1. Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer.

Author
de Carpeno JC; Baron MG; Aguiar J; Chacon JI; Feliu J; Garcia MJ; Madronal C; Colmenarejo A; Sanchez JJ; Ordonez A;
Institution
Department of Medical Oncology, La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain. jcastro.hulp@salud.madrid.org
Journal
Cancer Chemother Pharmacol. 2006 Aug;58(2):266-71. Epub 2005 Nov 25.
Abstract URL
Click here to view abstract

2. Targeted therapies in combination with chemotherapy in non-small cell lung cancer.

Author
Johnson DH;
Institution
Vanderbilt-Ingram Cancer Center and Division of Hematology and Oncology, Vanderbilt University School of Medicine Nashville, Tennessee 37232-6307, USA. david.johnson@vanderbilt.edu
Journal
Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4451s-4457s.
Abstract URL
Click here to view abstract

3. Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy.

Author
Hotta K; Fujiwara Y; Matsuo K; Suzuki T; Kiura K; Tabata M; Takigawa N; Ueoka H; Tanimoto M; Hotta K; Fujiwara Y; Matsuo K; Suzuki T; Kiura K; Tabata M; Takigawa N; Ueoka H; Tanimoto M;
Institution
Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan. khotta@md.okayama-u.ac.jp
Journal
Cancer. 2007 Mar 1;109(5):939-48.
Abstract URL
Click here to view abstract

4. Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer.

Author
Weiss GJ; Langer C; Rosell R; Hanna N; Shepherd F; Einhorn LH; Nguyen B; Paul S; McAndrews P; Bunn PA Jr; Kelly K;
Institution
University of Colorado Health Sciences Center, Division of Medical Oncology Center, Aurora, CO 80010, USA.
Journal
J Clin Oncol. 2006 Sep 20;24(27):4405-11.
Abstract URL
Click here to view abstract

5. Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials.

Author
Bria E; Cuppone F; Ciccarese M; Nistico C; Facciolo F; Milella M; Izzo F; Terzoli E; Cognetti F; Giannarelli D;
Institution
Department of Medical Oncology, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Roma, Italy. emiliobria@yahoo.com.it
Journal
Cancer Treat Rev. 2006 Dec;32(8):583-7. Epub 2006 Aug 21.
Abstract URL
Click here to view abstract